Thomas A. Puchalski
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Cancer Research top 5%
- Co-authors
- Shobha SeetharamJohann S. de BonoDavid P. RyanRocio García‐CarboneroJeffrey G. SupkoBirge BernsRobert G. MakiDavid C. Harmon
- Topics
- Multiple Myeloma Research and Treatments (14 papers)Monoclonal and Polyclonal Antibodies Research (12 papers)Chronic Lymphocytic Leukemia Research (9 papers)
- Cited by
- OncologyImmunologyHematology
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Thomas A. Puchalski
50 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.5k
- Molecular Biology 905
- Pulmonary and Respiratory Medicine 834
- Immunology 789
- Cancer Research 413
Countries citing papers authored by Thomas A. Puchalski
This map shows the geographic impact of Thomas A. Puchalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Puchalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Puchalski more than expected).
Fields of papers citing papers by Thomas A. Puchalski
This network shows the impact of papers produced by Thomas A. Puchalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Puchalski. The network helps show where Thomas A. Puchalski may publish in the future.
Co-authorship network of co-authors of Thomas A. Puchalski
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Puchalski. A scholar is included among the top collaborators of Thomas A. Puchalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Puchalski. Thomas A. Puchalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 63 | |
| 3 | 10 | |
| 4 | 166 | |
| 5 | 26 | |
| 6 | 228 | |
| 7 | 11 | |
| 8 | 3 | |
| 9 | 54 | |
| 10 | 93 | |
| 11 | 86 | |
| 12 | 47 | |
| 13 | 42 | |
| 14 | 57 | |
| 15 | 3 | |
| 16 | 250 | |
| 17 | 29 | |
| 18 | 21 | |
| 19 | 55 | |
| 20 | 23 |
About Thomas A. Puchalski
Thomas A. Puchalski is a scholar working on Hematology, Oncology and Genetics, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (789 citations) and Hematology (362 citations). Thomas A. Puchalski has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Shobha Seetharam, Johann S. de Bono, David P. Ryan, Rocio García‐Carbonero, Jeffrey G. Supko, Birge Berns, Robert G. Maki, David C. Harmon, José Jimeno and George D. Demetri. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.